Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Optic neuropathy and blindness associated with crizotinib for non-small-cell lung cancer with EML4-ALK translocation.

× No keyword cloud information.

9 in total

1. Late-onset Ocular Toxicity Presenting as Uveitis Caused by Crizotinib.

Authors: Megumi Iseki; Toshikatsu Kaburaki; Makoto Aihara; Hiromasa Sawamura
Journal: Neuroophthalmology Date: 2021-05-06

Review 2. Targeted Cancer Therapy and Its Ophthalmic Side Effects: A Review.

Authors: Shruthi Harish Bindiganavile; Nita Bhat; Andrew G Lee; Dan S Gombos; Nagham Al-Zubidi
Journal: J Immunother Precis Oncol Date: 2021-02-25

3. Neurological complications of new chemotherapy agents.

Authors: Alicia M Zukas; David Schiff
Journal: Neuro Oncol Date: 2018-01-10 Impact factor: 12.300

Review 4. Neuro-ophthalmic side effects of molecularly targeted cancer drugs.

Authors: M T Bhatti; A K S Salama
Journal: Eye (Lond) Date: 2017-10-20 Impact factor: 3.775

Review 5. Ocular Toxicity of Targeted Anticancer Agents.

Authors: Blake H Fortes; Prashant D Tailor; Lauren A Dalvin
Journal: Drugs Date: 2021-03-31 Impact factor: 9.546

6. Ocular toxicities associated with targeted anticancer agents: an analysis of clinical data with management suggestions.

Authors: Chen Fu; Dan S Gombos; Jared Lee; Goldy C George; Kenneth Hess; Andrew Whyte; David S Hong
Journal: Oncotarget Date: 2017-05-05

7. Clinical data from the real world: efficacy of Crizotinib in Chinese patients with advanced ALK-rearranged non-small cell lung cancer and brain metastases.

Authors: Puyuan Xing; Shouzheng Wang; Xuezhi Hao; Tongtong Zhang; Junling Li
Journal: Oncotarget Date: 2016-12-20

8. Damage to the Superior Retinae After 30 Gy Whole-Brain Radiation.

Authors: Lawrence Chan; Penny K Sneed; Jonathan C Horton
Journal: Adv Radiat Oncol Date: 2021-04-18

9. Final results of the large-scale multinational trial PROFILE 1005: efficacy and safety of crizotinib in previously treated patients with advanced/metastatic ALK-positive non-small-cell lung cancer.

Authors: Fiona Blackhall; D Ross Camidge; Alice T Shaw; Jean-Charles Soria; Benjamin J Solomon; Tony Mok; Vera Hirsh; Pasi A Jänne; Yuankai Shi; Pan-Chyr Yang; Tommaso De Pas; Toyoaki Hida; Javier De Castro Carpeño; Silvana Lanzalone; Anna Polli; Shrividya Iyer; Arlene Reisman; Keith D Wilner; Dong-Wan Kim
Journal: ESMO Open Date: 2017-08-17

9 in total